Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing

Heart Rhythm

Volumn 13, Issue 1, 2016, Pages 299-310

  Adler, Arnon ^a   Rosso, Raphael ^a   Chorin, Ehud ^a   Havakuk, Ofer ^a   Antzelevitch, Charles ^b   Viskin, Sami ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Brugada syndrome; Cardiac arrest; Electrocardiogram; Electrophysiologic study; Risk stratification; Ventricular fibrillation

Indexed keywords

BRUGADA SYNDROME; CLINICAL FEATURE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FAINTNESS; GENE; GENE MUTATION; HEART ARREST; HEART REPOLARIZATION; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE FIBRILLATION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; REVIEW; RISK ASSESSMENT; SCN5A GENE; SIGNAL PROCESSING; SUDDEN DEATH; T WAVE; COMPLICATION; HEART FUNCTION TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; VENTRICULAR FIBRILLATION;

BRUGADA SYNDROME; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART ARREST; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; VENTRICULAR FIBRILLATION;

EID: 84955452489     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.08.038     Document Type: Article

References (90)

1. P. Brugada, and J. Brugada Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report J Am Coll Cardiol 20 1992 1391 1396
2. B. Benito, A. Sarkozy, L. Mont, and et al. Gender differences in clinical manifestations of Brugada syndrome J Am Coll Cardiol 52 2008 1567 1573
3. S. Viskin, and O. Rogowski Asymptomatic Brugada syndrome: a cardiac ticking time-bomb? Europace 9 2007 707 710
4. A.A. Wilde, and S. Viskin EP testing does not predict cardiac events in Brugada syndrome Heart Rhythm 8 2011 1598 1600
5. S. Viskin, and R. Rosso Risk of sudden death in asymptomatic Brugada syndrome: not as high as we thought and not as low as we wished.but the contrary J Am Coll Cardiol 56 2010 1585 1588
6. F. Sacher, V. Probst, P. Maury, and et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study - part 2 Circulation 128 2013 1739 1747
7. S. Miyazaki, T. Uchiyama, Y. Komatsu, and et al. Long-term complications of implantable defibrillator therapy in Brugada syndrome Am J Cardiol 111 2013 1448 1451
8. G. Conte, J. Sieira, G. Ciconte, and et al. Implantable cardioverter-defibrillator therapy in Brugada syndrome. A 20-year single-center experience J Am Coll Cardiol 65 2015 879 888
9. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
10. P. Delise, G. Allocca, N. Sitta, and P. DiStefano Event rates and risk factors in patients with Brugada syndrome and no prior cardiac arrest: a cumulative analysis of the largest available studies distinguishing ICD-recorded fast ventricular arrhythmias and sudden death Heart Rhythm 11 2014 252 258
11. V. Probst, C. Veltmann, L. Eckardt, and et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry Circulation 121 2010 635 643
12. S. Kamakura, T. Ohe, K. Nakazawa, and et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3 Circ Arrhythm Electrophysiol 2 2009 495 503
13. S.G. Priori, A.A. Wilde, M. Horie, and et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes Heart Rhythm 10 2013 1932 1963
14. J. Sieira, G. Conte, G. Ciconte, C. de Asmundis, G.B. Chierchia, G. Baltogiannis, G. Di Giovanni, Y. Saitoh, G. Irfan, R. Casado-Arroyo, J. Juliá, M. La Meir, F. Wellens, K. Wauters, S. Van Malderen, G. Pappaert, and P. Brugada Prognostic value of programmed electrical stimulation in Brugada syndrome: 20 years experience Circ Arrhythm Electrophysiol 8 2015 777 784
15. Y. Kaneko, M. Horie, S. Niwano, and et al. Electrical storm in patients with Brugada syndrome is associated with early repolarization Circ Arrhythm Electrophysiol 7 2014 1122 1128
16. B. Belhassen, A. Glick, and S. Viskin Efficacy of quinidine in high-risk patients with Brugada syndrome Circulation 110 2004 1731 1737
17. B. Belhassen, and S. Viskin Near fatal ventricular fibrillation in Brugada syndrome despite presence of an implanted implantable cardioverter defibrillator Can J Cardiol 30 1460 2014 e1463 e1465
18. T. Miyazaki, H. Mitamura, S. Miyoshi, K. Soejima, Y. Aizawa, and S. Ogawa Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome J Am Coll Cardiol 27 1996 1061 1070
19. K. Mizumaki, A. Fujiki, T. Tsuneda, and et al. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome J Cardiovasc Electrophysiol 15 2004 667 673
20. M. Yokokawa, H. Okamura, T. Noda, and et al. Neurally mediated syncope as a cause of syncope in patients with Brugada electrocardiogram J Cardiovasc Electrophysiol 21 2010 186 192
21. F. Sacher, F. Arsac, S.B. Wilton, and et al. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome Heart Rhythm 9 2012 1272 1279
22. L.R. Olde Nordkamp, A.S. Vink, A.A. Wilde, and et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes Heart Rhythm 12 2015 367 375
23. Y. Take, H. Morita, N. Toh, and et al. Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome Heart Rhythm 9 2012 752 759
24. S.G. Priori, M. Gasparini, C. Napolitano, and et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry J Am Coll Cardiol 59 2012 37 45
25. F. Sacher, P. Meregalli, C. Veltmann, and et al. Are women with severely symptomatic Brugada syndrome different from men? J Cardiovasc Electrophysiol 19 2008 1181 1185
26. T. Kamakura, M. Wada, I. Nakajima, and et al. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada Syndrome Circ Arrhythm Electrophysiol 8 2015 785 791
27. S. Viskin Brugada syndrome in children: don't ask, don't tell? Circulation 115 2007 1970 1972
28. S.G. Priori, C. Napolitano, U. Giordano, G. Collisani, and M. Memmi Brugada syndrome and sudden cardiac death in children Lancet 355 2000 808 809
29. G. Conte, W. Dewals, J. Sieira, and et al. Drug-induced Brugada syndrome in children: clinical features, device-based management, and long-term follow-up J Am Coll Cardiol 63 2014 2272 2279
30. V. Probst, I. Denjoy, P.G. Meregalli, and et al. Clinical aspects and prognosis of Brugada syndrome in children Circulation 115 2007 2042 2048
31. A. Adler, G. Topaz, K. Heller, and et al. Fever induced type I Brugada pattern: how common is it and what does this mean? Heart Rhythm 10 2013 1375 1382
32. D.I. Keller, H. Huang, J. Zhao, and et al. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation Cardiovasc Res 70 2006 521 529
33. G. Conte, C. de Asmundis, G. Ciconte, and et al. Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms J Am Med Assoc 312 2014 2039 2041
34. S. Viskin, R. Rosso, L. Friedensohn, O. Havakuk, and A.A. Wilde Everybody has Brugada syndrome until proven otherwise? Heart Rhythm 12 2015 1595 1598
35. G. Conte, C DEA, J. Sieira, and et al. Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome J Cardiovasc Electrophysiol 25 2014 514 519
36. M.J. Ackerman Genetic purgatory and the cardiac channelopathies: exposing the variants of uncertain/unknown significance (VUS) Issue Heart Rhythm 12 2015 2325 2331
37. P. Maury, A. Rollin, F. Sacher, and et al. Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome Am J Cardiol 112 2013 1384 1389
38. S.G. Priori, C. Napolitano, M. Gasparini, and et al. Natural history of Brugada syndrome: insights for risk stratification and management Circulation 105 2002 1342 1347
39. P.G. Meregalli, H.L. Tan, V. Probst, and et al. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies Heart Rhythm 6 2009 341 348
40. J.M. Cordeiro, H. Barajas-Martinez, K. Hong, and et al. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome Circulation 114 2006 2026 2033
41. L. Nunez, A. Barana, I. Amoros, and et al. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient Heart Rhythm 10 2013 264 272
42. S. Poelzing, C. Forleo, M. Samodell, and et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene Circulation 114 2006 368 376
43. P.C. Viswanathan, D.W. Benson, and J.R. Balser A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation J Clin Invest 111 2003 341 346
44. C.R. Bezzina, J. Barc, Y. Mizusawa, and et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death Nat Genet 45 2013 1044 1049
45. E. Sommariva, C. Pappone, F. Martinelli Boneschi, and et al. Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification Eur J Hum Genet 21 2013 911 917
46. H. Morita, K. Kusano-Fukushima, S. Nagase, and et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome J Am Coll Cardiol 40 2002 1437 1444
47. K.F. Kusano, M. Taniyama, K. Nakamura, and et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds J Am Coll Cardiol 51 2008 1169 1175
48. M.A. Bigi, A. Aslani, and S. Shahrzad Clinical predictors of atrial fibrillation in Brugada syndrome Europace 9 2007 947 950
49. C. Giustetto, N. Cerrato, E. Gribaudo, and et al. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis Heart Rhythm 11 2014 259 265
50. K. Tokioka, K.F. Kusano, H. Morita, and et al. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities J Am Coll Cardiol 63 2014 2131 2138
51. P. Delise, G. Allocca, E. Marras, and et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach Eur Heart J 32 2011 169 176
52. Y. Mizusawa, and A.A. Wilde Brugada syndrome Circ Arrhythm Electrophysiol 5 2012 606 616
53. C. Veltmann, T. Papavassiliu, T. Konrad, and et al. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging Heart Rhythm 9 2012 414 421
54. H. Okamura, T. Kamakura, H. Morita, and et al. Risk stratification in patients with Brugada syndrome without previous cardiac arrest Circ J 79 2015 310 317
55. H. Makimoto, E. Nakagawa, H. Takaki, and et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome J Am Coll Cardiol 56 2010 1576 1584
56. R. Brugada, J. Brugada, C. Antzelevitch, and et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts Circulation 101 2000 510 515
57. G. Conte, J. Sieira, A. Sarkozy, and et al. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis Heart Rhythm 10 2013 1869 1874
58. A. Rollin, F. Sacher, J.B. Gourraud, and et al. Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome Heart Rhythm 10 2013 1012 1018
59. T. Tada, K.F. Kusano, S. Nagase, and et al. Clinical significance of macroscopic T-wave alternans after sodium channel blocker administration in patients with Brugada syndrome J Cardiovasc Electrophysiol 19 2008 56 61
60. S. Rolf, H.J. Bruns, T. Wichter, and et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol Eur Heart J 24 2003 1104 1112
61. C. Veltmann, C. Wolpert, F. Sacher, and et al. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges Europace 11 2009 1345 1352
62. H. Morita, K.F. Kusano, D. Miura, and et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome Circulation 118 2008 1697 1704
63. S. Sakamoto, M. Takagi, H. Tatsumi, and et al. Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome Heart Vessels 2015 [Epub ahead of print] http://dx.doi.org/10.1007/s00380-015-0692-y
64. M.J. Junttila, P. Brugada, K. Hong, and et al. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients J Cardiovasc Electrophysiol 19 2008 380 383
65. M.A. Babai Bigi, A. Aslani, and S. Shahrzad aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome Heart Rhythm 4 2007 1009 1012
66. V.N. Batchvarov, M. Govindan, A.J. Camm, and E.R. Behr Brugada-like changes in the peripheral leads during diagnostic ajmaline test in patients with suspected Brugada syndrome Pacing Clin Electrophysiol 32 2009 695 703
67. P. Crea, G. Picciolo, F. Luzza, and G. Oreto ST segment depression in the inferior leads in Brugada pattern: a new sign Ann Noninvasive Electrocardiol 2014 [Epub ahead of print] http://dx.doi.org/10.1111/anec.12247
68. A. Adler, R. Rosso, D. Viskin, A. Halkin, and S. Viskin What do we know about the "malignant form" of early repolarization? J Am Coll Cardiol 62 2013 863 868
69. S. Viskin, A. Adler, and R. Rosso Brugada burden in Brugada syndrome: the way to go in risk stratification? Heart Rhythm 10 2013 1019 1020
70. A. Sarkozy, G.B. Chierchia, G. Paparella, and et al. Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome Circ Arrhythm Electrophysiol 2 2009 154 161
71. M. Takagi, K. Aonuma, Y. Sekiguchi, Y. Yokoyama, N. Aihara, and M. Hiraoka The prognostic value of early repolarization (J wave) and ST-segment morphology after J wave in Brugada syndrome: multicenter study in Japan Heart Rhythm 10 2013 533 539
72. R. Rosso, E. Glikson, B. Belhassen, and et al. Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology Heart Rhythm 9 2012 225 229
73. H. Kawata, H. Morita, Y. Yamada, and et al. Prognostic significance of early repolarization in infero-lateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation Heart Rhythm 10 2013 1161 1168
74. H. Kasanuki, S. Ohnishi, M. Ohtuka, and et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease Circulation 95 1997 2277 2285
75. K. Nademanee, G. Veerakul, S. Nimmannit, and et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men Circulation 96 1997 2595 2600
76. T. Ikeda, M. Takami, K. Sugi, Y. Mizusawa, H. Sakurada, and H. Yoshino Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest Ann Noninvasive Electrocardiol 10 2005 396 403
77. K. Yoshioka, M. Amino, W. Zareba, and et al. Identification of high-risk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms Circ J 77 2013 610 618
78. Y. Uchimura-Makita, Y. Nakano, T. Tokuyama, and et al. Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome J Cardiovasc Electrophysiol 25 2014 1021 1027
79. J. Brugada, R. Brugada, and P. Brugada Electrophysiologic testing predicts events in Brugada syndrome patients Heart Rhythm 8 2011 1595 1597
80. P. Brugada, R. Brugada, and J. Brugada Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation 112 2005 279 292
81. J. Sieira, G. Ciconte, G. Conte, and et al. Asymptomatic Brugada syndrome: clinical characterization and long term prognosis Circ Arrhythm Electrophysiol 2015 [Epub ahead of print] http://dx.doi.org/10.1161/CIRCEP.114.003044
82. M. Paul, J. Gerss, E. Schulze-Bahr, and et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data Eur Heart J 28 2007 2126 2133
83. M. Takagi, Y. Sekiguchi, Y. Yokoyama, N. Aihara, M. Hiraoka, and K. Aonuma Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the EHRA/APHRS Expert Consensus Statement: multicenter study in Japan Heart Rhythm 11 2014 1716 1720
84. B. Belhassen, and Y. Michowitz Arrhythmic risk stratification by programmed ventricular stimulation in Brugada syndrome: the end of the debate? Circ Arrhythm Electrophysiol 8 2015 757 759
85. H. Makimoto, S. Kamakura, N. Aihara, and et al. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram Heart Rhythm 9 2012 242 248
86. M. Takagi, Y. Yokoyama, K. Aonuma, N. Aihara, and M. Hiraoka Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with Brugada syndrome: multicenter study in Japan J Cardiovasc Electrophysiol 18 2007 1244 1251
87. P. Brugada, P. Geelen, R. Brugada, L. Mont, and J. Brugada Prognostic value of electrophysiologic investigations in Brugada syndrome J Cardiovasc Electrophysiol 12 2001 1004 1007
88. P. Brugada, R. Brugada, L. Mont, M. Rivero, P. Geelen, and J. Brugada Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart J Cardiovasc Electrophysiol 14 2003 455 457
89. P.G. Postema, C. Wolpert, A.S. Amin, and et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website Heart Rhythm 6 2009 1335 1341 http://www.brugadadrugs.org
90. S. Viskin, A.A. Wilde, H.L. Tan, C. Antzelevitch, W. Shimizu, and B. Belhassen Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry Heart Rhythm 6 2009 401 404